Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
181,259,081
-
Total 13F shares
-
19,798,633
-
Share change
-
+2,916,737
-
Total reported value
-
$496,205,288
-
Price per share
-
$25.16
-
Number of holders
-
47
-
Value change
-
+$62,122,502
-
Number of buys
-
33
-
Number of sells
-
21
Institutional Holders of Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC) as of Q3 2021
As of 30 Sep 2021,
Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC) was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,798,633 shares.
The largest 10 holders included
FMR LLC, Casdin Capital, LLC, FEDERATED HERMES, INC., RA CAPITAL MANAGEMENT, L.P., Avidity Partners Management LP, BlackRock Inc., Logos Global Management LP, HHLR ADVISORS, LTD., Octagon Capital Advisors LP, and Marshall Wace North America L.P..
This page lists
47
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.